IMNN-101
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for IMNN-101, covering 2025-07-23 to 2025-07-23. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate the Safety & Immunogenicity of IMNN-101 Administered in Healthy Adults Previously Vaccinated Against SARS-CoV-2 [Phase 1, Phase 2]